A cluster of inhibitory residues in the regulatory domain prevents activation of the cystic fibrosis transmembrane conductance regulator
Min Wu, Yawei Xiong, Mengyuan Cao, Yunqi Zhi, Yan Jin, Yizhen Huang, Jeng-Haur Chen

TL;DR
The study identifies a cluster of residues in the CFTR protein that prevents its activation until phosphorylated, offering insights into cystic fibrosis.
Contribution
The discovery of an inhibitory module formed by residues R766, S768, M773, and T774 that blocks CFTR activation.
Findings
Deleting residues 760–783 in CFTR leads to constitutive channel activity without PKA phosphorylation.
Residues R766, S768, M773, and T774 form an inhibitory module preventing CFTR activation.
Modifying these residues with cysteine mutations results in PKA-independent channel activity.
Abstract
Activation of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl‒ channel requires PKA phosphorylation at the regulatory (R) domain to relieve inhibition of ATP-dependent channel activity. This study aimed to identify the primary inhibitory site that prevents channel activation. CFTR mutants with deletion of residues 760 to 783 (ΔR760–783) elicited constitutive macroscopic and single-channel Cl‒ currents in the presence of ATP before PKA phosphorylation, suggesting that protein segment R760–783 in the R domain blocks CFTR activation. With the background of ΔR760–835, further deletion of R708–759 led to fully active channels in the presence of ATP, but the absence of PKA, suggesting that R708–759 prevents the activation of ΔR760–835-CFTR. R760–783 peptides were unstructured in buffered solutions in CD spectroscopy and the N771P mutation that interrupts the α-helix…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCystic Fibrosis Research Advances · Neonatal Respiratory Health Research · Asthma and respiratory diseases
